 Aprea Therapeutics NASDAQ:APRE Director Scott M. Rocklage sold 245,000 shares of the businesss stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of 28.75, for a total transaction of 7,043,750.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. NASDAQ ... 